Telemedicine market in 'BRIC' countries set to grow to $418 million by 2014
According to the new market research report, titled Telemedicine Market in Brazil, Russia, India, China (BRIC) - Advanced technologies, Global Forecast and published by MarketsandMarkets, the BRIC telemedicine is expected to reach a market size of $418.4 million by the year 2014, at a compound annual growth rate (CAGR) of 15.8% from 2009-2014.
Within this, the BRIC telemedicine technology market is expected to reach a size of $307.4 million by the year 2014 growing at a CAGR of 16.6% from 2009-2014 and BRIC telemedicine service market will reach $111 million in 2014 with CAGR of 13.8%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze